Lybalvi

olanzapine and samidorphan

Approval

ApplicationNDA 213378
Approval dateMay 28, 2021
Approval year2021
SponsorAlkermes INC

FDA-approved use

To treat schizophrenia and certain aspects of bipolar I disorder

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Lybalvi: